Pricing Log in Create free account

SeaStar Medical Holding Corporation (ICU) vs MetaVia Inc. (MTVA)

SeaStar Medical Holding Corporation and MetaVia Inc. are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $7.2M — 1.4× the size. MetaVia Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, MetaVia Inc. leads on 8 and SeaStar Medical Holding Corporation on 3.

Valuation

Metric ICU MTVA Biotechnology median
P/E n/m n/m 10.26
P/S 4.53 n/m 9.18
P/B 1.81 0.92 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.17 0.65
EV/Sales 1.96 n/m 8.98
Earnings yield (205.79%) (377.38%) (34.89%)
Free cash flow yield (176.47%) (251.86%) (24.52%)

Profitability

Metric ICU MTVA Biotechnology median
Gross margin 92.64% — 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (175.68%) (50.12%)
Return on assets (160.02%) (91.06%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ICU MTVA Biotechnology median
Revenue growth (TTM) 123.63% — 6.26%
EPS growth (last fiscal year) 91.16% 81.23% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 2.06 4.89
Net debt to EBITDA 0.99 0.75 1.01

Dividend

Metric ICU MTVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ICU MTVA Biotechnology median
Market cap 10.20m 7.18m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack